The implant, which costs 100 euros, will allow people to have their vaccine passports implanted to make them easily-scannable.
Militaries around the world have focused on aerial drones. Now, a DARPA project wants to put a drone underwater for months.
Attackers accessed email accounts containing Social Security numbers, medical treatment information, and more.
๐๐๐ ๐๐ง๐๐๐ช๐๐ฉ๐ ๐พ๐๐ฃ๐ฉ๐๐ง ๐ค๐ ๐๐๐ ๐พ๐๐ฉ๐ฎ ๐๐ฃ๐๐ซ๐๐ง๐จ๐๐ฉ๐ฎ ๐ค๐ ๐๐๐ฌ ๐๐ค๐ง๐ :
The Neuro-Network.
๐๐๐๐๐ฃ๐ฉ๐๐จ๐ฉ๐จ ๐๐๐๐ฃ๐ฉ๐๐๐ฎ ๐๐ช๐ฉ-๐ฟ๐๐ง๐๐ซ๐๐ ๐๐๐ฉ๐๐๐ค๐ก๐๐ฉ๐๐จ ๐ฉ๐๐๐ฉ ๐๐ก๐๐ฎ ๐ ๐๐ค๐ก๐ ๐๐ฃ ๐๐๐ช๐ง๐ค๐๐๐๐๐ฃ๐๐ง๐๐ฉ๐๐ค๐ฃ
๐๐๐ ๐๐๐จ๐๐ค๐ซ๐๐ง๐ฎ ๐๐๐ซ๐๐ฃ๐๐๐จ ๐ช๐ฃ๐๐๐ง๐จ๐ฉ๐๐ฃ๐๐๐ฃ๐ ๐ค๐ ๐ฉ๐๐ ๐ง๐ค๐ก๐ ๐ค๐ ๐๐ช๐ฉ-๐๐ง๐๐๐ฃ ๐๐ค๐ข๐ข๐ช๐ฃ๐๐๐๐ฉ๐๐ค๐ฃ๐จ ๐โฆ See more.
The discovery advances understanding of the role of gut-brain communications in the development of multiple sclerosis and homes in on a potential therapeutic target
NEW YORK, December 20, 2021 โ A New York-based, multi-institutional research team has found high levels of three toxic metabolites produced by gut bacteria in the cerebrospinal fluid and plasma samples of multiple sclerosis (MS) patients. The important findings, published in the journal Brain, further scientistsโ understanding of how gut bacteria can impact the course of neurological diseases by producing compounds that are toxic to nerve cells.
Previously published evidence has supported the concept that an imbalance in the gut microbiotaโthe community of organisms that live in the human intestinesโmay underly a range of neurological disorders. Researchers also found that certain gut bacteria are either enriched or depleted in MS patients compared to healthy individuals, but it is unclear how these microbes communicate with the brain and affect the neurodegenerative disease process.
Get Surfshark VPN at https://Surfshark.deals/thoughty2 and enter promo code THOUGHTY2 for 83% off and 4 extra months for free!
Get my new book Bread and Circuses: https://bit.ly/breadandcircusesbook.
Listen to my new podcast Random Interesting Facts: http://bit.ly/RIFThoughty2
Or watch it on YouTube: http://bit.ly/RIFPodcastYT
Thoughty2 Audiobook: https://geni.us/t2audio.
Thoughty2 Book: https://geni.us/t2book.
Support Me & Get Early Access: http://bit.ly/t2club.
Thoughty2 Merchandise: https://bit.ly/t2merch.
Follow Thoughty2
Facebook: https://facebook.com/thoughty2
Instagram: https://instagram.com/thoughty2
Website: http://thoughty2.com.
About Thoughty2
Thoughty2 (Arran) is a British YouTuber and gatekeeper of useless facts. Thoughty2 creates mind-blowing factual videos about science, tech, history, opinion and just about everything else.
#Thoughty2
When we think about gene editing, the first thing we remember is the designer babies, and that itโs usually called unethical. But actually, gene editing (CRISPR) may be one of the most promising upcoming medical technologies. Learn why in this video.
Check out other videos from this series:
https://www.youtube.com/playlist?list=PLnWSi4zEceYXPCBYXZ9ZEV-9q44ebksoo.
0:00 โ Opening scene.
0:20 โ Gene editing is promising. Hereโs why.
2:35 โ Also, it can transform the beauty industry.
3:49 โ How does gene editing work?
4:16 โ My thoughts on that.
5:16 โ End credits.
Text me: [email protected].
Business inquiries: [email protected].
Directed by Valentin Shevtsov.
ยฉ Shevtsov Originals, 2021.
#dna #science #medicine.
#geneediting #genetherapy #crispr #alzheimers
Europe will soon produce a strategically vital component in the modern global economy as US semiconductor giant Intel chooses the site for a new cutting-edge chip factory.
Recent problems in global supply chains have highlighted the fundamental importance of semiconductors, which are used in a growing number of products including cars, TVs and smartphones.
Keen demand and the closure of semiconductor plants, particularly in Asia, due to pandemic disruptions led to a global chip shortage and forced car manufacturers such as Ford, Nissan and Volkswagen to scale back production.
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
All 18 hospitalized individuals administered the treatment developed by Israeli biotech company Amorphical in a phase II trial recovered and were discharged in a few days.
When three is not enough.
Israel has announced a fourth dose of the COVID-19 vaccine to people older than 16. The additional dose will be given to senior citizens, medical workers, people with suppressed immune system.
#Israel #COVID #ImmuneSystem.
About Channel:
WION-The World is One News, examines global issues with in-depth analysis. We provide much more than the news of the day. Our aim to empower people to explore their world. With our Global headquarters in New Delhi, we bring you news on the hour, by the hour. We deliver information that is not biased. We are journalists who are neutral to the core and non-partisan when it comes to the politics of the world. People are tired of biased reportage and we stand for a globalised united world. So for us the World is truly One.
Please keep discussions on this channel clean and respectful and refrain from using racist or sexist slurs as well as personal insults.
Check out our website: http://www.wionews.com.
Connect with us on our social media handles:
Facebook: https://www.facebook.com/WIONews.
Twitter: https://twitter.com/WIONews.
Follow us on Google News for latest updates.
Companies and labs are racing to build next-generation devices that track and translate brain activity to help people immobilized by disease or injury handle tasks requiring movement.
Artificial intelligence (AI) backed drug discovery company Insilico Medicine announced last week that it was dosing the first healthy volunteer in a microdose trial of ISM 001โ005. Designed with the help of AI, the drug is a small-molecule inhibitor of a biological target that was discovered by Pharma. AI. The trial is being conducted in Australia.
The AI-designed drug will be used to treat chronic lung disease idiopathic pulmonary fibrosis, or IPF usually leads to progressive and irreversible lung-function decline and affects 20 people out of over 100,000 globally.
Chief Scientific Officer of Insilico, Freng Ren, said in a press release that this drug discovery and trial marks a significant milestone in the AI-drug discovery space. This is because the said candidate is the first-ever AI-discovered novel molecule based on an AI-discovered target.
